{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:14:32Z","timestamp":1791404072042,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["971798"],"award-info":[{"award-number":["971798"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["963231"],"award-info":[{"award-number":["963231"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["971176"],"award-info":[{"award-number":["971176"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.taap.2022.115951","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T01:09:19Z","timestamp":1645924159000},"page":"115951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer"],"prefix":"10.1016","volume":"440","author":[{"given":"Fereshteh","family":"Asgharzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Mostafapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safieh","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forouzan","family":"Amerizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihaneh","family":"Sabbaghzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Fakhraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alieh","family":"Farshbaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.115951_bb0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.15171\/apb.2016.066","article-title":"Venlafaxine-induced cytotoxicity towards isolated rat hepatocytes involves oxidative stress and mitochondrial\/lysosomal dysfunction","volume":"6","author":"Ahmadian","year":"2016","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.taap.2022.115951_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0042-123034","article-title":"Mechanistic approach for toxic effects of bupropion in primary rat hepatocytes","volume":"67","author":"Ahmadian","year":"2017","journal-title":"Drug Res."},{"key":"10.1016\/j.taap.2022.115951_bb0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s12272-016-0766-0","article-title":"In vitro and in vivo evaluation of the mechanisms of citalopram-induced hepatotoxicity","volume":"40","author":"Ahmadian","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.taap.2022.115951_bb0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopha.2018.01.117","article-title":"Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2","volume":"99","author":"Ahmadian","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2022.115951_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pestbp.2017.11.009","article-title":"Betanin reduces organophosphate induced cytotoxicity in primary hepatocyte via an anti-oxidative and mitochondrial dependent pathway","volume":"144","author":"Ahmadian","year":"2018","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.taap.2022.115951_bb0030","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.2174\/1381612825666190111145140","article-title":"The therapeutic potential of angiotensin-converting enzyme and angiotensin receptor inhibitors in the treatment of colorectal cancer: rational strategies and recent progress","volume":"24","author":"Asgharzadeh","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2022.115951_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3831\/KPI.2018.21.032","article-title":"Thymoquinone prevents myocardial and perivascular fibrosis induced by chronic lipopolysaccharide exposure in male rats:-thymoquinone and cardiac fibrosis","volume":"21","author":"Asgharzadeh","year":"2018","journal-title":"J. Pharmacopuncture"},{"key":"10.1016\/j.taap.2022.115951_bb0040","series-title":"Inhibition of Angiotensin II Type I Pathway Reduced Tumor Growth and Ameliorates Fibrosis\/Inflammation Associated with Colorectal Cancer","author":"Asgharzadeh","year":"2020"},{"key":"10.1016\/j.taap.2022.115951_bb0045","first-page":"75","article-title":"Induction of apoptosis by green synthesized gold nanoparticles through activation of caspase-3 and 9 in human cervical cancer cells","volume":"8","author":"Baharara","year":"2016","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.taap.2022.115951_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cellsig.2005.05.003","article-title":"Necrosis is associated with IL-6 production but apoptosis is not","volume":"18","author":"Berghe","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.taap.2022.115951_bb0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00228-014-1755-1","article-title":"Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions","volume":"70","author":"Biagi","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2022.115951_bb0060","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10495-007-0082-8","article-title":"Apoptosis by cisplatin requires p53 mediated p38\u03b1 MAPK activation through ROS generation","volume":"12","author":"Bragado","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.taap.2022.115951_bb0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2022.115951_bb0070","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1291\/hypres.30.1205","article-title":"Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients","volume":"30","author":"Chujo","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.taap.2022.115951_bb0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/HJH.0b013e328344a7de","article-title":"Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals","volume":"29","author":"Collaboration","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.taap.2022.115951_bb0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial","volume":"13","author":"de Gramont","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2022.115951_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.taap.2022.115951_bb0090","first-page":"1893","article-title":"Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling","volume":"27","author":"Du","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2022.115951_bb0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/21691401.2017.1315427","article-title":"Hepatoprotective and free radical scavenging actions of quercetin nanoparticles on aflatoxin B1-induced liver damage: in vitro\/in vivo studies","volume":"46","author":"Eftekhari","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.taap.2022.115951_bb0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0042-110178","article-title":"Triazole rizatriptan induces liver toxicity through lysosomal\/mitochondrial dysfunction","volume":"66","author":"Fard","year":"2016","journal-title":"Drug Res."},{"key":"10.1016\/j.taap.2022.115951_bb0105","first-page":"295","article-title":"Telmisartan is a potent target for prevention and treatment in human prostate cancer","volume":"20","author":"Funao","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2022.115951_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000097258","article-title":"Melatonin and immunomodulation: connections and potential clinical applications","volume":"13","author":"Giannoulia-Karantana","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.taap.2022.115951_bb0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MPA.0b013e3181c314cd","article-title":"Blocking angiotensin II type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells","volume":"39","author":"Gong","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.taap.2022.115951_bb0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1593\/neo.08380","article-title":"Type I collagen receptor (\u03b12\u03b21) signaling promotes prostate cancer invasion through RhoC GTPase","volume":"10","author":"Hall","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.taap.2022.115951_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic resistance in colorectal cancer: a review","volume":"8","author":"Hammond","year":"2016","journal-title":"Therapeut. Adv. Med. Oncol."},{"key":"10.1016\/j.taap.2022.115951_bb0130","first-page":"506","article-title":"Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer","volume":"20","author":"Hashemzehi","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.taap.2022.115951_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/mco.2014.438","article-title":"Effect of Paullinia cupana on MCF-7 breast cancer cell response to chemotherapeutic drugs","volume":"3","author":"Hertz","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.taap.2022.115951_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1470-2045(03)01277-4","article-title":"Anticancer therapy targeting the apoptotic pathway","volume":"4","author":"Hu","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2022.115951_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10620-007-9838-9","article-title":"Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells","volume":"53","author":"Huang","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.taap.2022.115951_bb0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.bjc.6605143","article-title":"Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells","volume":"101","author":"Kirkland","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2022.115951_bb0155","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1158\/0008-5472.CAN-05-2804","article-title":"Collagen type I induces disruption of E-cadherin\u2013mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells","volume":"66","author":"Koenig","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2022.115951_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.20486","article-title":"Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer","volume":"67","author":"Kosaka","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.taap.2022.115951_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ndt\/gfp525","article-title":"An in-vitro tumour microenvironment model using adhesion to type I collagen reveals Akt-dependent radiation resistance in renal cancer cells","volume":"25","author":"Krasny","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.taap.2022.115951_bb0170","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ijo.2017.3846","article-title":"Regulation of EMT by STAT3 in gastrointestinal cancer","volume":"50","author":"Li","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2022.115951_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01756-y","article-title":"Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf\/MAPK\/AP-1 pathway and MMP-9 production in osteosarcoma","volume":"39","author":"Liu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.taap.2022.115951_bb0180","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1158\/1535-7163.MCT-08-0715","article-title":"Combination of antiangiogenesis with chemotherapy for more effective cancer treatment","volume":"7","author":"Ma","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2022.115951_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1081\/CEH-200067668","article-title":"Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements","volume":"27","author":"Nishimura","year":"2005","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.taap.2022.115951_bb0190","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/or.2017.5977","article-title":"Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest","volume":"38","author":"Oura","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2022.115951_bb0195","doi-asserted-by":"crossref","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: A strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochimica Biophysica Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.taap.2022.115951_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2022.115951_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120007","article-title":"Therapeutic implications from sensitivity analysis of tumor angiogenesis models","volume":"10","author":"Poleszczuk","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2022.115951_bb0210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2402090","article-title":"Phosphorylation of Bcl2 and regulation of apoptosis","volume":"15","author":"Ruvolo","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2022.115951_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03044961","article-title":"Morphologic criteria and detection of apoptosis","volume":"24","author":"Saraste","year":"1999","journal-title":"Herz"},{"key":"10.1016\/j.taap.2022.115951_bb0220","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/jcp.29053","article-title":"Novel oral transforming growth factor-\u03b2 signaling inhibitor potently inhibits postsurgical adhesion band formation","volume":"235","author":"Soleimani","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2022.115951_bb0225","first-page":"863","article-title":"Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer","volume":"20","author":"Tabatabai","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.taap.2022.115951_bb0230","series-title":"Metastasis Research Protocols","first-page":"121","article-title":"Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography","author":"Toth","year":"2012"},{"key":"10.1016\/j.taap.2022.115951_bb0235","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(15)30574-6","article-title":"911 A novel use of angiotensin II receptor blocker (ARB) losartan to inhibit AOM induced tumorigenesis and neoangiogenesis in experimental colon cancer","volume":"148","author":"Valuckaite","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2022.115951_bb0240","first-page":"565","article-title":"Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on angiogenesis of gastric cancer in a nude mouse model","volume":"11","author":"Wang","year":"2008","journal-title":"Zhonghua wei chang wai ke za zhi= Chinese J. Gastrointest. Surg."},{"key":"10.1016\/j.taap.2022.115951_bb0245","first-page":"413","article-title":"Apigenin inhibits growth and induces G2\/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells","volume":"21","author":"Yin","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2022.115951_bb0250","first-page":"1227","article-title":"Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells","volume":"20","author":"Yoshiji","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2022.115951_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/138161210789941883","article-title":"The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies","volume":"16","author":"Zivny","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2022.115951_bb0260","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3390\/molecules25112614","article-title":"Drug-drug interactions of irinotecan, 5-fluorouracil, folinic acid and oxaliplatin and its activity in colorectal carcinoma treatment","volume":"25","author":"Zoetemelk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2022.115951_bb0265","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jprot.2013.10.020","article-title":"Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis","volume":"94","author":"Zou","year":"2013","journal-title":"J. Proteome"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:47:11Z","timestamp":1777456031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X22000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":53,"alternative-id":["S0041008X22000965"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.115951","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.115951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115951"}}